This bill reorganizes the Corporation for National and Community Service into a new executive department called the AmeriCorps Administration, which would oversee national service programs. It creates a seven-member Advisory Board with representatives from different age groups and political parties to advise on program policies and priorities. The legislation increases financial support for participants by raising living allowances and educational awards, while also establishing a new National Service Foundation to accept private donations for the programs. Additionally, the bill sets a goal of serving 1 million participants annually by 2036 and creates an outreach program to notify young people aged 17-30 about service opportunities.
This bill, known as the Diabetes Foot Health Access and Modernization Act of 2026, makes two main changes to federal healthcare programs. First, it allows Medicaid to cover foot and ankle care services provided by podiatric physicians, ensuring patients have access to this specialized care. Second, it updates Medicare rules to clarify documentation requirements for diabetic shoes, specifying conditions under which patients can receive extra-depth or custom-molded footwear. The changes take effect on January 1, 2026, for Medicaid services and January 1, 2028, for Medicare shoe coverage.
The Gas Prices Relief Act of 2026 would temporarily suspend federal gasoline taxes and the Leaking Underground Storage Tank Trust Fund financing rate from its enactment until October 1, 2026, aiming to reduce costs for consumers who purchase gasoline. Specifically, it sets the federal excise tax on gasoline to zero during this period. To prevent funding shortfalls, the bill directs the Treasury to transfer equivalent amounts from the general fund to the Highway Trust Fund and the Leaking Underground Storage Tank Trust Fund. It also includes a policy that the tax reduction should be passed on to consumers and empowers the Secretary of the Treasury to ensure this, potentially through monetary penalties for producers and dealers who do not reduce prices.
This bill directs the Joint Committee of Congress on the Library to commission and place a statue of Clarence Mitchell, Jr. in a permanent public location within the United States Capitol. The legislation authorizes the committee to enter into agreements with an artist or organization to create the statue and permits the Architect of the Capitol to handle related contracts on the committee's behalf. Funding is authorized to cover the costs of obtaining and installing the statue, with no specific time limit for spending the allocated funds. The bill honors Mitchell, Jr., a civil rights leader and former NAACP Washington Bureau director, by recognizing his contributions to civil rights legislation through a physical memorial in the Capitol.
This bill, known as the No Tax on Drill Pay Act, would exclude certain military compensation from federal income tax. It directly affects members of the U.S. military who receive pay for inactive-duty training, which includes weekend drills and other training activities outside of regular duty. The legislation amends the Internal Revenue Code to add inactive-duty training compensation to the list of qualified military benefits that are not subject to taxation. This change applies to any compensation received after the bill becomes law, meaning it would affect future training pay rather than past earnings.
This bill would remove the federal approval for the drug mifepristone, which is used in combination with other medications to end pregnancies, and would make it illegal to distribute the drug for that purpose. It also creates a new federal lawsuit option allowing individuals to sue drug manufacturers for physical or mental harm they claim resulted from using mifepristone. The law would take effect 14 days after passing, with the new lawsuit provision becoming active 90 days after enactment.
This bill, titled the Critical Minerals Investment Tax Modernization Act of 2026, changes how mining companies calculate tax deductions for extracting rare earth minerals. It directly affects businesses that mine rare earth elements by increasing their allowable percentage depletion rate from the current standard to 22 percent. The specific minerals covered include the 15 lanthanide elements and scandium, which are now added to the list of resources eligible for this higher tax deduction. The change applies to taxable years beginning after the bill is enacted, allowing companies to deduct a larger portion of their mining costs from their taxable income.
HRES 1110 is a non-binding House resolution expressing the U.S. House of Representatives' disapproval of the slaughter of dogs and cats for human consumption and urging Japan to enact a nationwide ban. It references the U.S. 2018 ban on this practice (under the Agriculture Improvement Act) and notes similar bans in South Korea, Taiwan, and cities like Shenzhen and Jakarta. The resolution affirms shared U.S.-Japan values on animal welfare, encourages bilateral cooperation on animal rights, and clarifies it does not interfere with protected cultural or religious practices. As a symbolic diplomatic statement, it has no legal force but aims to influence Japan’s policies on animal welfare.
This bill, titled the Healthy Competition for Better Care Act, prohibits health insurance companies and group health plans from entering into contracts with healthcare providers that include certain anticompetitive restrictions. Specifically, it bans agreements that prevent insurers from steering patients toward different providers, require insurers to make additional agreements with related entities, force payment rate agreements with affiliates not involved in the contract, or stop other insurers from paying lower rates for the same services. The law includes exceptions for certain types of healthcare networks like health maintenance organizations and value-based care arrangements, allows states to grandfather existing contracts for up to 10 years if they are unlikely to reduce competition, and requires federal agencies to create implementing regulations within one year of enactment.
This bill, titled the Interstate Milk Freedom Act of 2026, would prevent federal agencies from blocking the sale of unpasteurized milk and milk products across state lines. It allows such products to be shipped interstate if they are packaged for direct human consumption, produced in a state that permits their sale, and intended for another state that also allows their distribution. The legislation defines specific terms like "cowshare" to include ownership interests in dairy animals and clarifies what constitutes pasteurization. Importantly, the bill does not override state laws and only restricts federal interference when the product meets the stated conditions.
This bill would require infant formula manufacturers to conduct standardized testing for specific pathogens and microorganisms in both their facilities and finished products. It mandates that companies report positive test results to the FDA within one business day and retain records of these findings for inspections. The legislation also requires the FDA to notify congressional committees within one business day of receiving positive test results or issuing certain inspection classifications. Additionally, the bill establishes clear inspection standards that apply to all infant formula products regardless of where they are made.
HR 7871 (MVP Act) updates Medicaid drug rebate rules to allow manufacturers to report multiple "best price points" for drugs sold under outcome-based payment arrangements, requiring these arrangements to be offered to all states. It clarifies how average manufacturer price is calculated for such drugs and exempts certain outcome-linked payments from anti-kickback laws. The bill also mandates a GAO study to assess whether these arrangements improve patient access, lower costs, and reduce disparities in drug coverage. This affects Medicaid programs nationwide, drug manufacturers, and patients receiving covered outpatient drugs under Medicaid.
